Prime Medicine, Inc.PRMENASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+20.8%
5Y CAGR+130.5%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+20.8%/yr
Annual compound
5Y CAGR
+130.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
65x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$205.66M+0.1%
2024$205.45M+0.3%
2023$204.79M+75.7%
2022$116.54M+38.0%
2021$84.47M+2571.5%
2020$3.16M+45.6%
2019$2.17M-